Impacto materno-infantil dos tratamentos de câncer na gravidez
Palavras-chave:
Câncer na gravidez, Tratamento do câncer, Radioterapia, Quimioterapia na gravidezResumo
A principal causa de morte de mulheres em idade reprodutiva é o câncer. No entanto, o câncer durante a gravidez é um evento raro e seu maior desafio é o diagnóstico precoce. As alterações fisiológicas que ocorrem durante a gestação podem mascarar os sinais e sintomas da doença, causando significativo impacto materno-fetal. Os tratamentos mais utilizados são quimioterapia, radioterapia e tratamento cirúrgico, sendo que o principal obstáculo para o sucesso terapêutico é alcançar o equilíbrio entre a intervenção imediata para a indicação materna e o retardo na terapia para a indicação fetal. O presente trabalho tem como objetivo descrever sobre os impactos materno-fetais dos diferentes tipos de tratamentos de câncer durante a gravidez. Para o seu desenvolvimento foi realizada revisão integrativa da literatura com busca nas bases de dados Public Medline (PubMed) e Scientific Eletronic Library Online (Scielo). Observou-se que o tratamento cirúrgico e a quimioterapia são os tratamentos de escolha por apresentarem menos riscos para a mãe e o feto se realizados durante o segundo trimestre de gravidez. Já a radioterapia se apresenta incerta com relação a suas consequências, mas pode ser considerada se os benefícios forem maiores que os riscos.
Referências
AZNAB, M.; NANKALI, A.; DAEICHIN, S. Determination of Clinical Process and Response Rate to Treatment in Patients with Gestational Trophoblastic Neoplasia (GTN) with Low and High Risk and Evaluation of Their First Pregnancy Outcome. International Journal of Hematology-Oncology and Stem Cell Research, v. 12, n. 4, p. 291–297, 2018.
BAE, S. Y.; KIM, K. S. Neoadjuvant chemotherapy and prognosis of pregnancy-associated breast cancer: A time-trends study of the Korean breast cancer registry database. Journal of Breast Cancer, v.21, n.4, p. 425–432, 2018.
BEKSAC, K. et al. Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma. Oncology Research and Treatment, v.40, n. 7-8, p. 441–445, 2017.
BLANQUISETT, A. H. et al. Breast cancer in pregnancy: an institutional experience. eCancer Medical Science, v. 9, p. 551, 2015.
CORDEIRO, C. N.; GEMIGNANI, M. L. Breast cancer in pregnancy: Avoiding fetal harm when maternal treatment is necessary. The Breast Journal, v.23, n. 2, p. 200–205, 2017.
FIGUEIRO, E.A.; AL-SUM, H.; PARRISH, J.; WUNDER, J. S.; MAXWELL, C. Maternal and fetal outcomes in pregnancies affected by bone and soft tissue tumors. American Journal of Perinatology Reports, v.8, n.4, p. e343–e348, 2018.
GAROFALO, S. et al. Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy? European Journal of Cancer Care, v. 26, n. 6, p. 1–7, 2016.
HEPNER, A. et al. Cancer During Pregnancy: The Oncologist Overview. World Journal of Clinical Oncology, v. 10, n. 1, p. 28-34, 2019.
KRIDIS, W. et al. The Difficulties in the Management of Breast Cancer and Pregnancy. Reviews on Recent Clinical Trials, v. 11, n. 2, p. 141–144, 2016.
KOZASA, K. et al. Estrogen stimulates female cancer progression by inducing myeloidderived suppressive cells: investigations on pregnant and non-pregnant experimental models. Oncotarget, v.10, n. 20, p. 1887-1902, 2019.
LEONARDI, M. et al. Electron Beam Intraoperative Radiotherapy (ELIOT) in Pregnant Women with Breast Cancer: From in Vivo Dosimetry to Clinical Practice. Breast Care (Basel), v.12, n. 6, p. 396–400, 2017.
LU, D. et al. Maternal Cancer During Pregnancy and Risks of Stillbirth and Infant Mortality. Journal of Clinical Oncology. v. 35, n. 14, p. 1522-1529, 2017.
MELAN, K. et al. Pregnancy-associated-cancer in the French West Indies (Martinique): maternal and neonatal outcomes. BMC Pregnancy Childbirth, v.17, n.1, p. 334, 2017.
NATIONAL CANCER INSTITUTE. Conselho Editorial do PDQ Adult Treatment. Breast Cancer Treatment During Pregnancy (PDQ)–Health Professional Version. Atualizado <29/03/2019>. Disponível em: <https://www.cancer.gov/types/breast/hp/pregnancy-breasttreatment-pdq> . Acessado em: 20 de abril de 2019.
RATO, I. et al. Adnexal tumor in pregnancy - how to manage?. Acta Obstetrica e Ginecologica Portuguesa. v. 11, n.2, p. 113-121, 2017.
SATO, K. et al. Treatment of oral cancers during pregnancy: a case-based discussion. Journal of Otolaryngology, v.48, n.9, p. 1-7, 2019.
VERHEECKE, M. et al. Genetic and microscopic assessment of the human chemotherapyexposed placenta reveals possible pathways contributive to fetal growth restriction. Placenta, v. 64, p. 61–70, 2018.
WALSH, E. et al. Is chemotherapy always required for cancer in pregnancy? An observational study. Irish Journal of Medical Science, v. 186, n. 4, p. 875-881, 2017.
WANG, B. et al. Clinicopathological characteristics, diagnosis, and prognosis of pregnancyassociated breast cancer. Thoracic Cancer, v. 10, p. 1060-1068, 2019.
ZHANG, X.; GAO, Y.; YANG, Y. Treatment and prognosis of cervical cancer associated with pregnancy: analysis of 20 cases from a chinese tumor institution. Journal of Zhejiang University, v. 16, n. 5, p. 388-394, 2015.
